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The clinically silent Plasmodium liver stage is an
obligatory step in the establishment of malaria infec-
tion and disease. We report here that expression of
heme oxygenase-1 (HO-1, encoded by Hmox1) is
upregulated in the liver following infection by
Plasmodiumberghei andPlasmodiumyoelii sporozo-
ites. HO-1 overexpression in the liver leads to a pro-
portional increase in parasite liver load, and treatment
of mice with carbon monoxide and with biliverdin,
each an enzymatic product of HO-1, also increases
parasite liver load. Conversely, mice lacking Hmox1
completely resolve the infection. In the absence of
HO-1, the levels of inflammatory cytokines involved
in the control of liver infection are increased. These
findings suggest that, while stimulating inflammation,
the liver stage of Plasmodium also induces HO-1 ex-
pression, which modulates the host inflammatory
response, protecting the infected hepatocytes and
promoting the liver stage of infection.
INTRODUCTION
Plasmodium, the causative agent of malaria, has a very complex
life cycle involving both an invertebrate definitive host (the female
Anopheles mosquito) and a vertebrate host. In the mammalian
host, Plasmodium infection comprises distinct stages. Infection
is initiatedwhensporozoites are placed in the skinbyanAnopheles
mosquito (Amino et al., 2006; Vanderberg and Frevert, 2004),
where they remain until they find a blood vessel (Yamauchi et al.,
2007) and travel to the liver sinusoid, where they recognize and
interact withhighly sulfated liver HSPGs (Coppi et al., 2007; Frevert
et al., 1993). Once arrested in the liver sinusoid, sporozoites are
proposed to reach the hepatocytes by passing through Kupffer
cells (Frevert et al., 2005). Sporozoites then migrate through
several hepatocytes before invading a final one (Frevert et al.,2005; Mota et al., 2001). There, inside a parasitophorous vacuole,
a single sporozoite initiates a developmental program, which
results in the production of 10,000 to 30,000 merozoites inside
a single hepatocyte. These are then released in the bloodstream
(Baer et al., 2007; Sturm et al., 2006), where each merozoite
invades an erythrocyte, initiating a replication cycle that ends
with the release of new merozoites from the infected erythrocyte
(schizont), which go on to infect other erythrocytes.
Malaria-associated pathology only occurs during the blood
stage of infection. Thus, while hepatocyte-Plasmodium interac-
tions during the liver stage constitute an ideal target for interven-
tion strategies aiming to block Plasmodium life cycle and
infection, the blood stages of infection constitute the ultimate
goal for therapeutic strategies against the disease. Despite the
powerful prophylactic potential of host factors that influence liver
infection, they remain poorly understood. This is partially due to
the fact that infected hepatocytes are very few in number.
Heme oxygenase (HO) is the rate-limiting enzyme in the catab-
olism of free heme. It breaks down the porphyrin ring of heme to
yield equimolar amounts of biliverdin, free iron (Fe2+), and carbon
monoxide (CO) (Tenhunen et al., 1968). To date, three isoforms
of heme oxygenase have been identified (HO-1, HO-2, and
HO-3), all products of different genes (Maines, 1988; McCoubrey
et al., 1992; McCoubrey et al., 1997; Ryter et al., 2006). Under
normal physiological conditions, most cells express low or unde-
tectable levels of HO-1 protein, while HO-2 is constitutively
expressed. The pattern of HO-3 expression awaits further char-
acterization. Hmox1 gene expression is strongly induced by
a highly diverse set of agents, including, among others, heavy
metals, LPS, hypoxia, heat shock, cytokines, and its substrate,
heme (for review see Wagener et al., 2003). The heme-HO sys-
tem has been involved in many physiological and pathophysio-
logical processes, by affording cytoprotection (Brouard et al.,
2000) and due to its anti-inflammatory effects (Otterbein et al.,
2000). We have previously shown that HO-1 plays a crucial
role in suppressing malaria pathology during the blood stage of
infection, as HO-1 expression controls susceptibility to cerebral
malaria in mice (Pamplona et al., 2007). HO-1 was found to be
upregulated to a lesser extent in infected C57BL/6 mice, whichCell Host & Microbe 3, 331–338, May 2008 ª2008 Elsevier Inc. 331
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(ECM), than in infected BALB/c mice, which do not develop
ECM. Moreover, deletion of Hmox1 or inhibition of HO activity
in BALB/c mice increased ECM incidence to 83% and 78%, re-
spectively (Pamplona et al., 2007). More recently, a microarray-
based analysis of host cell genes altered during the course of
sporozoite infection identified HO-1 as one of the genes that is
upregulated (five-fold increase in expression versus noninfected
controls) in a hepatoma cell line following P. berghei sporozoite
infection (S.A. and M.M.M., unpublished data). We now report
that HO-1 promotes the establishment of the malaria liver stage
of infection. Thus, HO-1 is a host molecule that strongly influ-
ences both the establishment of the Plasmodium liver stage of
infection and the development of pathology during the blood
stage of a malaria infection.
RESULTS
P. berghei and P. yoelii Sporozoite Infection
Upregulates Host HO-1
In the course of an as yet unpublished microarray analysis of host
genes altered during the course of sporozoite infection, we found
that HO-1 was upregulated 5.9-fold in Hepa1-6 cells infected with
P. berghei sporozoites (S.A. and M.M.M., unpublished data). It
has been described that, upon exposure to a variety of stress
stimuli such as cytokines, endotoxin, hypoxia, and oxidative
stress, the liver induces HO-1 and overproduces CO (Maines
and Gibbs, 2005). To extend our in vitro observation to an in
vivo situation, we evaluated HO-1 induction, both at the mRNA
and protein level, during liver infection by P. berghei sporozoites.
HO-1 is upregulated in vivo duringP. berghei infection in the liver,
as measured by quantitative real time-PCR (qRT-PCR) (Fig-
ure 1A). Immunohistochemistry analysis confirms an upregula-
tion of HO-1 in the liver, with an intense staining in Kupffer cells
(which are liver-resident macrophages) and leukocytes (Fig-
ure 1B). Double staining with antibodies directed against HO-1
and a macrophage-specific marker confirms that HO-1 is indeed
induced in macrophages and Kupffer cells (Figure 1C).
Next, we sought to determine whether a similar increase in HO-1
expression would occur when mice were infected with P. yoelii
sporozoites, which produce higher liver infection loads (Khan
and Vanderberg, 1991). The results clearly show that infected he-
patocytes isolated 24 hr and 40 hr after liver infection show a sig-
nificant upregulation of HO-1 expression (Figure 1E). Moreover,
this upregulation could be observed when P. yoelii sporozoites
were incubated with hepatoma cells or mouse macrophages
(Figures 1F and 1G). Together, these results demonstrate that
host HO-1 expression is induced in both hepatocytes and macro-
phages during in vitro and in vivo infection by P. berghei and
P. yoelii sporozoites, presenting the possibility that HO-1 might
play an important role during the liver stage of infection.
HO-1 Expression Is Required for the Establishment
of P. berghei and P. yoelii Liver Infection
To investigate the function of HO-1 during the course of liver
stage infection by P. berghei sporozoites, we used HO-1-defi-
cient (Hmox1/) and wild-type (Hmox1+/+) BALB/c mice. None
of the Hmox1/ mice infected with 103 P. berghei sporozoites
became positive for a blood stage infection, while all of the332 Cell Host & Microbe 3, 331–338, May 2008 ª2008 Elsevier Inc.Hmox1+/+ mice became positive by day 4 after sporozoite injec-
tion (Figure 2A). To determine whether the observed requirement
in infection is due to an effect in the liver infection, Hmox1/
and Hmox1+/+ BALB/c mice were infected with a higher dose
of P. berghei or P. yoelii sporozoites (2 3 104), and infection
load was measured 40 hr later by qRT-PCR for Plasmodium
18S rRNA. Lack of HO-1 expression reduces both P. berghei
and P. yoelii infection by 71.6% ± 16.9% and 62.8% ± 18.5%,
respectively, as compared to infection in Hmox1+/+ (n = 6 mice
per group, p < 0.01, and n = 3 mice per group, p < 0.05, respec-
tively; Figure 2B).
Next, we sought to determine whether a liver-specific inhibi-
tion of HO-1 would lead to the same decrease in infection.
RNAi-based target knockdown in vivo in livers of rodents and
livers of nonhuman primates has previously been demonstrated
after systemic siRNA administration of cholesterol-conjugated
siRNAs (Soutschek et al., 2004) and siRNAs encapsulated in sta-
ble lipid nanoparticles (Zimmermann et al., 2006), respectively. In
our experiments, a single systemic i.v. administration of 5 mg/kg
HO-1-specific siRNA in liposomal nanoparticles resulted in
a 60% HO-1 mRNA knockdown in the liver of adult mice, com-
pared to HO-1 mRNA in the liver of animals treated with the
same dose of a formulated control siRNA directed against lucif-
erase. mRNA levels were determined by qRT-PCR analysis of
tissue extracts prepared 64 hr after siRNA injection (data not
shown). The effect of siRNA-mediated HO-1 mRNA reduction
on sporozoite-induced infection was evaluated by measuring
the percentage of infected red blood cells using fluorescence-
activated cell sorting (FACS). None of the HO-1 siRNA-treated
mice showed any patent parasitemia, whereas animals treated
with control siRNA develop a normal course of infection (Fig-
ure 2C). Collectively, these data clearly demonstrate that induc-
tion of HO-1 in the liver is required for the efficient establishment
of infection.
Overexpression of HO-1 Increases P. berghei
Liver Infection
The above experiments implicate HO-1, induced in the liver by
sporozoite infection, as an important host factor involved in the
establishment of the Plasmodium liver stage. Next, we wanted
to determine whether exogenous induction of HO-1 could also
lead to a more efficient establishment of liver stage infection.
To this end, we used a HO-1-expressing adenovirus (Ad-HO-1).
Mice treated with a noncoding adenovirus (Ad Null) were used as
controls. The results visibly demonstrate that a single injection of
Ad-HO-1 leads to an increase of HO-1 expression in the liver (p <
0.05; Figure 2D, gray bars), when compared to HO-1 mRNA
levels in the livers of mice treated with Ad Null, as measured
by qRT-PCR. Importantly, a proportional increase in liver infec-
tion by P. berghei sporozoites is observed following the HO-1
overexpression (p < 0.05; Figure 2D, black bars). Overall, these
data reveal that Plasmodium liver infection correlates with the
hepatic levels of HO-1 expression.
Exogenous CO or Biliverdin Increases
Hepatic Infection In Vivo
Next, we sought to determine whether the effect of HO-1 on
infection could be mediated by any of the end-products of
HO-1 enzymatic activity. First, treatment of mice with
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HO-1 Promotes Plasmodium Liver InfectionFigure 1. HO-1 Is Upregulated during P.
berghei and P. yoelii Liver Infection
(A) HO-1 mRNA expression significantly increases
in the liver of BALB/c mice 40 hr after infection with
105 sporozoites, when compared to noninfected
mice (NI) injected with material of noninfected
mosquito salivary glands, as measured by qRT-
PCR (n = 4 mice per group, p < 0.05). Error bars
represent mean ± SD.
(B) Immunohistochemistry, using anti-HO-1-
specific antibodies, of liver tissue sections 40 hr
after infection confirms upregulation of HO-1 ex-
pression in liver when compared to noninfected
mice. Specific staining is only observed in infected
liver sections and is confined to Kupffer and leuko-
cytes (arrows). Scale bar, 50 mm.
(C) Immunofluorescence costaining of HO-1 (green)
and macrophages (anti-F4/80 antibody, red) in
mouse infected livers confirms that HO-1 is
strongly upregulated in macrophages in livers of
infected mice. Cell nuclei are stained with 4060-dia-
midino-2-phenylindole (DAPI, blue). Magnifica-
tion 633.
(D) HO-1 mRNA expression significantly increases
in mouse peritoneal macrophages incubated for
18 hr with P. berghei sporozoites, when compared
to macrophages incubated with material of nonin-
fected mosquito salivary glands, as measured by
qRT-PCR (n = 3 per group, p < 0.05). Error bars
represent mean ± SD.
(E–G) P.yoelii sporozoites induce significant HO-1
upregulation in isolated mouse hepatocytes after
24 and 40 hr (in vivo infection) (E); 24 hr infected
human hepatoma cells versus noninfected cells
(NI) in the same plate (F); and mouse peritoneal
macrophages incubated for 18 hr with P. yoelii
sporozoites, when compared to macrophages in-
cubated with material of noninfected mosquito
salivary glands (G). All data were measured by
qRT-PCR (n = 4 per group, p < 0.05). Error bars
represent mean ± SD.exogenous biliverdin (35 mg/kg i.p. twice per day for 3 days) fol-
lowed by P. berghei sporozoite infection led to a 3-fold increase
in liver infection, as compared to mock-treated mice (p < 0.05,
n = 10) (Figure 3A). In parallel, both C57BL/6 and BALB/c mice
were infected with 23 104 sporozoites and then exposed to CO
(250 parts per million [p.p.m.]) for the entire period of the infec-
tion (40 hr). Mice kept under normal atmospheric conditions
were used as controls. The quantification of parasite load in
the livers was performed 40 hr after infection by P. berghei.
Both strains of mice show a 4-fold increase in P. berghei liver
infection when exposed to exogenous CO, as compared to in-
fected mice exposed to air (p < 0.05, n = 10 for each C57BL/6
and BALB/c background; Figure 3B). Thus, the data obtained
clearly suggest that the effect of HO-1 in Plasmodium liver
infection is the result of the action of at least two of the HO-1
enzymatic end-products. Moreover, they also suggest that the
Plasmodium liver burden in a typical infection does not corre-
spond to a saturation state but possibly reflects an equilibrium
between parasite and host mechanisms that controls parasite
expansion.CAbsence of HO-1 Has No Effect on Ex Vivo Hepatocyte
Infection
HO-1 is a pleiotropic inducible enzyme (Bilban et al., 2008;
Wagener et al., 2003). Thus, the role of HO-1 in liver infection
could be due to a direct effect of HO-1 on the infected hepato-
cyte or, conversely or simultaneously, to an effect on any other
cell that would interact or influence the outcome of infection in
the hepatocyte. To this end, mouse primary hepatocytes from
Hmox1/ and Hmox1+/+ mice were isolated and infected with
P. berghei sporozoites. The results clearly show that primary
hepatocyte infection ex vivo is not affected by the absence of
HO-1 (Figure 4A). This strongly suggests that the observed effect
of HO-1 on Plasmodium infection in vivo is a result of its effects
on cells other than the infected hepatocytes and that the affected
cells are capable of modulating the outcome of liver infection.
HO-1 Protects Infected Hepatocytes by Controlling the
Inflammatory Response
Induction of HO-1 expression in the liver by Plasmodium sporo-
zoites is necessary for the efficient establishment of the liverell Host & Microbe 3, 331–338, May 2008 ª2008 Elsevier Inc. 333
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effects of HO-1 on infected host hepatocytes. Since the anti-
inflammatory effects of HO-1 have been extensively character-
ized (Otterbein et al., 2003), we hypothesized that the induction
of HO-1 expression could be responsible for protecting infected
hepatocytes from an innate inflammatory response of the host. If
this were the case, one would predict that, in the absence of
HO-1, the infected hepatocytes would be targeted for destruc-
tion by this inflammatory response. To test this hypothesis, we
first analyzed histological sections of Hmox1/ and Hmox1+/+
mouse livers, in both BALB/c and C57BL/6 background, infected
with P. berghei sporozoites. Mice that were injected with nonin-
fected mosquito salivary gland material were used as baseline
controls (n = 9). This initial analysis immediately revealed the
expected, and previously reported (van de Sand et al., 2005),
existence of small inflammatory foci surrounding infected hepa-
tocytes in Hmox1+/+ mice (Figure 4B). Importantly, the number
Figure 2. HO-1 Is Necessary for an Efficient Liver Infection In Vivo
(A) Hmox1/ mice infected with 103 P. berghei sporozoites do not develop
blood stage infection, while allHmox1+/+ mice developed a patent parasitemia.
(B) Lack of HO-1 expression leads to a significant reduction in infection load.
Liver infection with 2 3 104 sporozoites is significantly reduced in Hmox1/
mice when compared to Hmox1+/+ mice (n = 6 mice per group, p < 0.05,
and n = 3 mice per group, p < 0.01 for P. berghei and P. yoelii, respectively),
as measured by qRT-PCR analysis of parasite 18S rRNA normalized to
HPRT in liver extracts taken 40 hr after sporozoite i.v. injection.
(C) Mice treated with HO-1-specific siRNA formulated in liposomal nanopar-
ticles do not develop blood stage infection after infection with 103 P. berghei
sporozoites, while all mice treated with control siRNA and infected in a similar
way developed a patent parasitemia.
(D) Overexpression of HO-1 increases P. berghei liver infection. Mice treated
with HO-1-expressing adenovirus (Ad-HO-1) show an increase of HO-1 ex-
pression in the liver (gray bars) and in liver infection load (black bars) (n = 4
mice per group, p < 0.01).
Error bars represent mean ± SD.334 Cell Host & Microbe 3, 331–338, May 2008 ª2008 Elsevier Inc.and size of these inflammatory foci were significantly higher in
Hmox1/ infected mice (p < 0.05, n = 6 and n = 3 for BALB/c
and C57BL/6 backgrounds, respectively; Figure 4C). Morpho-
metric analysis used to quantify the area occupied by these
inflammatory cells revealed a 4.8-fold and 3.7-fold increase in
the size of inflammatory foci in livers of infected Hmox1/
mice when compared to infected Hmox1+/+ mice, in BALB/c
and C57BL/6 backgrounds, respectively (p < 0.05, n = 6 and
n = 3; Figure 4D). Additionally, MIP-1a and MCP-1 chemokines,
known to be involved in the recruitment of leukocytes to the liver
(Lalor et al., 2002), were significantly upregulated in BALB/c
Hmox1/ infected mice (p < 0.001 and p < 0.005, respectively;
Figure 4E). Lineage marker-specific qRT-PCR also confirmed an
increase in proinflammatory cells in the liver of Hmox1/ in-
fected mice and revealed that both macrophages and neutro-
phils show a 3- to 5-fold significant increase when compared
toHmox1+/+ infected mice (p < 0.005 and p < 0.001, respectively;
Figure 4F). NK and T cells show a 2-fold increase, which does not
reach statistical significance. qRT-PCR analyses also showed
a significant increase in proinflammatory cytokines known to
help control malaria liver infection (Nussler et al., 1991; Sedegah
et al., 1994), such as TNF-a and IL-12 (p < 0.001), but not of
regulatory anti-inflammatory cytokines, such as IL-10 and
TGF-b (Figure 4G). In contrast, Ad-HO-1-mediated overexpres-
sion of HO-1 in the liver or exogenous CO administration did
not lead to an increase in the presence of inflammatory cells
(as evaluated by the expression of specific lineage markers) or
the level of proinflammatory cytokines in the liver (Figures 4F
Figure 3. Exogenous Biliverdin or CO Exacerbates Liver Infection
In Vivo
(A) Effect of biliverdin in vivo on mouse liver stage. BALB/c mice treated with
biliverdin show a 3-fold increase in P. berghei liver infection load (n = 5 mice
per group, p < 0.01).
(B) Effect of carbon monoxide (CO) in vivo on mouse liver stage. BALB/c (white
bars) and C57BL/6 (black bars) mice exposed to exogenous CO (250 ppm)
show a 4- to 6-fold increase in P. berghei liver infection, as compared to
infected mice exposed to air (n = 5 mice per group, p < 0.01).
Error bars represent mean ± SD.
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ghei Liver Infection Protects Infected Hepa-
tocytes by Controlling the Inflammatory Re-
sponse
(A) Lack of HO-1 has no effect on malaria hepatic
stage ex vivo. Quantification of EEFs in primary
hepatocytes from Hmox1/ mice and Hmox1+/+
mice 45 hr after infection. Results are expressed
as the mean ± SD of EEFs (%) (n = 6 coverslips
per group).
(B) Liver section showing representative inflam-
matory foci in Hmox1/ mice and Hmox1+/+ mice
(arrows). Scale bar, 50 mm.
(C) The number of inflammatory foci per mm2 on
BALB/c or C57BL/6 Hmox1/ mice is signifi-
cantly higher than that in Hmox1+/+ mice, which
in turn is higher than that in noninfected mice (NI)
injected with material of noninfected mosquito sal-
ivary glands (n = 6 and n = 3 for BALB/c and
C57BL/6 backgrounds, respectively, p < 0.05). Er-
ror bars represent mean ± SD.
(D) The area occupied by the inflammatory foci on
BALB/c or C57BL/6 Hmox1/ mouse liver sec-
tions is increased 5-fold compared to Hmox1+/+
mice (n = 6, p < 0.005, and n = 3, p < 0.05, for
BALB/c and C57BL/6 backgrounds, respectively).
Error bars represent mean ± SD.
(E) Quantification of MCP-1 and MIP-1ameasured
by qRT-PCR reaction and normalized to GAPDH
expression in the livers of Hmox1/ mice and
Hmox1+/+ mice (n = 6, p < 0.001 and p < 0.005). Er-
ror bars represent mean ± SD.
(F and G) Quantification of inflammatory cells (F)
and cytokines (G) in the livers of Hmox1/ mice
and Hmox1+/+ mice, HO-1 adenovirus-treated
mice, and exogenous CO-treated mice. The
mRNA levels of lineage markers were measured
by qRT-PCR analysis and normalized to HPRT in
liver extracts taken 40 hr after sporozoite i.v. injec-
tion. Results are plotted as fold change over the
respective controls, i.e., Hmox1+/+ mice, null ade-
novirus-treated mice, and mice exposed to normal
atmosphere, respectively. Error bars represent
mean ± SD.and 4G). As a whole, these results show that sporozoite infection
leads to an induction of HO-1, which in turn provides protection
to the developing Plasmodium parasites from the host inflamma-
tory response initiated by infection.
DISCUSSION
Understanding the biology of host-pathogen interactions occur-
ring during infection is essential to the design of new intervention
strategies against malaria. In this report, we show that liver infec-
tion by both P. berghei and P. yoelii sporozoites, which is crucial
for the establishment of the first obligatory developmental stage
of a malaria infection, leads to an upregulation of HO-1 in hepa-
tocytes and macrophages/leukocytes in the liver. Hmox1
deletion as well as HO-1 downmodulation using siRNA leads to
a complete abrogation of infection initiated with the minimal
numbers of P. berghei sporozoites that assure infection of
100% of mice (Vanderberg et al., 1968).
We had observed that in vitro infection of hepatoma cells with
P. berghei sporozoites leads to a significant increase in HO-1expression (S.A. and M.M.M., unpublished data). Here, we show
that in vivo liver infection with P. berghei and P. yoelii sporozoites
indeed induces HO-1 expression. Interestingly, using immuno-
histochemistry, we determined that the cells expressing higher
levels of HO-1 after sporozoite infection were mainly macro-
phages, including Kupffer cells. The lower levels of HO-1 upregu-
lation in hepatocytes upon infection were not detected by the
immunohistochemistry method used. Nevertheless, our results
using qRT-PCR of isolated infected cells clearly show that
P. yoelii infection results in a strong induction of HO-1 in infected
mouse hepatocytes in vivo and in human hepatoma cells.
It is not known what causes HO-1 induction during infection,
but the upregulation of gene expression likely results from the in-
terplay of multiple factors.Hmox1 gene expression is induced by
a diverse set of stimuli (Maines, 1997) and involves a multitude of
signaling pathways, including redox-dependent and -indepen-
dent paths (for review see Wagener et al., 2003). Liver infection
by Plasmodium sporozoites comprises sporozoite arrest in the
liver sinusoids, followed by crossing of the liver sinusoid and
migration through several hepatocytes before the invasion of aCell Host & Microbe 3, 331–338, May 2008 ª2008 Elsevier Inc. 335
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might be responsible for the induction of HO-1 in the liver. Since
a natural infection is initiated by a very small number of sporozo-
ites, the induction of HO-1 probably occurs at a local level.
Indeed, HO-1 upregulation in the whole liver is only detectable
when high numbers of sporozoites are used and results in only
a 4-fold increase. On the other hand, the level of HO-1 induction
in isolated infected cells from liver is much higher (12-fold
increase).
The diversity of nonheme HO-1 inducers has suggested for
some time now that the enzyme may perform several functions
not associated with heme degradation (Maines, 2000). Indeed,
HO-1 expression is increased in a variety of pathological condi-
tions, in which it has been shown to play crucial protective roles
(Otterbein and Choi, 2000). One of the most studied aspects of
HO-1 has been its anti-inflammatory effects (Otterbein et al.,
2000; Wagener et al., 2003). An inflammatory response mounted
against the liver stage of infection has been previously described
(van de Sand et al., 2005; Vanderberg et al., 1993). It has been
also proposed that the observed differences in infectivity
between P. berghei and P. yoelii infection in BALB/c mice or
between C57BL/6 and BALB/c mice infected with P. berghei
sporozoites are due to the differences in the host cellular inflam-
matory responses (Khan and Vanderberg, 1991; Scheller et al.,
1994). In agreement with these previous studies, our results
show that the number and size of the inflammatory foci in
P. berghei infection of wild-type C57BL/6 mice are higher than
those of BALB/c mice, correlating with the infection liver load.
Nevertheless, our results also show that this difference is main-
tained in the absence of HO-1, suggesting that HO-1 activity is
not the basis of the observed differences in infectivity. Indeed,
a malaria liver stage susceptibility locus, explaining the different
susceptibility between BALB/c and C57BL/6 mice, has been
identified on mouse chromosome 17 (Goncalves et al., 2008),
while the Hmox-1 gene is on mouse chromosome 8.
Now, we show in this report that induction of HO-1 in the liver
occurs in both P. berghei and P. yoelii infections and is crucial for
an efficient establishment of the initial obligatory stage of a ma-
laria infection, an effect that seems to be mediated by the control
of the host-inflammatory response. In vivo, lack of HO-1 leads to
an increase in the liver infiltrates, in both BALB/c and C57BL/6
backgrounds, and production of proinflammatory cytokines,
while lack of HO-1 does not influence infection ex vivo, in the
absence of the host inflammatory response, as primary hepato-
cytes from Hmox1/ mice show equivalent infection to those of
Hmox1+/+ mice.
These findings also suggest that the outcome of the host-
Plasmodium interaction is subject to intricate control and is de-
pendent on distinct roles of HO-1 in different tissues at different
stages of the Plasmodium life cycle. We have previously shown
that upregulation of HO-1 in mice injected with P. berghei ANKA-
infected red blood cells suppresses the establishment of exper-
imental cerebral malaria during the blood stage of infection
(Pamplona et al., 2007). Here, we show that upregulation of
HO-1 in the liver promotes the establishment of the initial stage
of a malaria infection, the liver stage. Thus, at different stages
of the Plasmodium life cycle, host HO-1 is playing distinct but
crucial roles. We also wondered whether the HO system would
be influencing the stages of the Plasmodium life cycle that336 Cell Host & Microbe 3, 331–338, May 2008 ª2008 Elsevier Inc.occurs in the invertebrate definitive host, the Anopheles mos-
quito. Indeed, a single HO gene with homology for mammalian
Hmox1 can be identified in both Drosophila and Anopheles
genomes, and Drosophila HO degrades hemin into biliverdin,
CO, and iron in the presence of reducing systems such as
NADPH/cytochrome P450 reductase and sodium ascorbate
(Zhang et al., 2004). Depletion of Anopheles HO, however, did
not lead to any difference in Plasmodium oocyst development
inside mosquito midgut (E. Levashina, personal communication),
suggesting that, while the HO system is crucial for both stages of
a malaria infection in the mammalian host, it may not play an
important role during the Plasmodium life cycle stages occurring
inside the Anopheles vector.
Variations in HO-1 expression are known to occur in human
populations, and a (GT)n microsatellite polymorphism in the
promoter region of the human Hmox1 gene seems to be to be
responsible for at least part of these variations. Preliminary evi-
dence suggests that the incidence of the homozygous short
GT-repeat (<28), which may afford a high level of HO-1 induction
during malaria infection, is increased in malaria patients who die
with malaria (Takeda et al., 2005). It has been shown that liver
parasite load correlates with the later development of malaria
severity (Alonso et al., 2004), and it is possible that this effect
is related to the role that HO-1 plays in the establishment of liver
stage infection. Further studies using larger populations will be
necessary to investigate the delicate balance that must exist in
the host to allow both the initial establishment of Plasmodium
infection in the liver and the later survival of the host during the
symptomatic blood stage. Moreover, these two stages may
coexist in the same individual in hyperendemic areas, which
may indicate additional levels of complexity in the role of HO-1
in the interplay between host and pathogen.
EXPERIMENTAL PROCEDURES
Parasites and Mice
Green fluorescent protein (GFP)-expressing P. berghei ANKA (parasite line
259cl2) or P. yoelii sporozoites (Franke-Fayard et al., 2004; Tarun et al.,
2006) were obtained by dissection of infected mosquito Anopheles
stenphensi. C57BL/6 and BALB/c mice were bred and housed in the specific
pathogen-free facilities of the Instituto Gulbenkian de Cieˆncia (IGC) according
to the Animal Care Committee of the IGC. Hmox1/ mice were generated by
mating Hmox1+/mice (backcrossed for ten generations into the BALB/c or
C57BL/6 background), as previously described (Yet et al., 1999). Littermate
Hmox1+/+ mice were used as controls. Mice were genotyped by tail genomic
DNA using the following primers: 50-TCTTGACGAGTTCTTCTGAG-30 and 50-A
CGAAGTGACGCCATCTGT-30; 50-GGTGACAGAAGAGGCTAAG-30 and 50-CT
GTACTCCACCTCCAAC-30.
In Vivo RNAi and Infection
BALB/c mice (male, 6–8 weeks) were treated with a single intravenous (i.v.)
administration of 5 mg/kg of siRNA formulated in a liposomal formulation (lipo-
somal nanoparticles) (Akinc et al., 2008). siRNAs targeting HO-1 had the
following sequence: sense strand: 50-GccGAGAAuGcuGAGuucAdTsdT-30,
antisense strand: 50-UGAACUcAGcAUUCUCGGCdTsdT-30; small letters indi-
cate 20-O-methyl modified residues, and ‘‘s’’ denotes a phosphorothioate
backbone linkage). A siRNA-targeting luciferase was used as control (sense
strand: cuuAcGcuGAGuAcuucGATsT, antisense strand: UCGAAGuACUc
AGCGuAAGTsT). Twenty-four hours after siRNA administration, mice were in-
fected by i.v. injection of 103 P. berghei sporozoites. Infection was allowed to
proceed to the blood stage, and parasitemia (percentage of infected red blood
cells) was measured daily. Remaining HO-1 mRNA levels in the livers of infected
mice were determined by qRTPCR 64 hr after siRNA administration.
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Mice were treated with a single i.v. administration of 2.8 3 108 pfu adenovirus
encoding HO-1 (Ad-HO-1) followed by infection with 23 104 sporozoites 48 hr
later. The overexpression of Hmox1 and parasite load were measured by qRT-
PCR 40 hr after infection. Noncoding adenovirus (Ad Null) administered in
a similar way was used as a control. The recombinant adenovirus expressing
the rat HO-1 cDNA has been described elsewhere (Soares et al., 2004). Re-
combinant adenoviruses were produced at the ‘‘plate-forme de production
de vecteurs viraux pre´-cliniques du CHU de Nantes’’ (Inserm UMR 649).
CO Exposure
Mice were placed in a gastight 60 l capacity chamber and exposed continu-
ously to CO for the duration of infection (40 hr) as described elsewhere (Otter-
bein et al., 2000). Briefly, 1% CO (Aga Linde) was mixed with air in a stainless
steel cylinder to obtain a final concentration of 250 ppm. CO was provided
continuously at a flow rate of 3 l/min. Concentration was monitored using
a carbon monoxide analyzer (Interscan Corporation, Chatsworth). Air controls
were maintained in a similar chamber without CO.
Gene-Specific Expression and Infection Quantification by qRT-PCR
Infection load in the liver was determined by qRT-PCR using P. berghei 18S
rRNA-specific primers as previously described (Bruna-Romero et al., 2001).
Gene-specific expression in liver was determined in a similar way using
gene-specific primers. External standardization was performed using plas-
mids encoding the full-length gene cDNA cloned in TOPO TA (Invitrogen).
The following primer sequences were used: mHmox1, TCTCAGGGGGTC
AGGTC-30 and 50-GGAGCGGTGTCTGGGATG-30; HPRT, 50-TGCTCGAGATG
TGATGAAGG-30 and 50-TCCCCTGTTGACTGGTCATT-3; Cd3e, 50-TCTCGGA
AGTCGAGGACAGT-30 and 50-ATCAGCAAGCCCAGAGTGAT-30; Il10, 50-TGC
TATGCTGCCTGCTCTTA-30 and 50-TCATTTCCGATAAGGCTTGG-30; IL12, 50-
AGGTGCGTTCCTCGTAGAGA-30 and 50-AAAGCCAACCAAGCAGAAGA-30;
Klrd1, 50-TCACTCGGTGGAGACTGATG-30 and 50-AGGCAAACACAGCATTC
AGA-30; Mgl2, 50-GGATCCCAAAATTCCCAGTT-30 and 50-TCCCTCTTCTCC
AGTGTGCT-30; Ncf2, 50-GCAGTGGCCTACTTCCAGAG-30 and 50-CTTCATGT
TGGTTGCCAATG-30;P. berghei 18S rRNA, 50-AGCATTAAATAAAGCGAATAC
ATCCTTAC-30 and 50-GGAGATTGGTTTTGACGTTTATGTG-30; P. yoelii 18S
rRNA, 50-GGGGATTGGTTTTGACGTTTTTGCG-30 and 50-AAGCATTAAATAAA
GCGAATACATCCTTAT-30; Tgfb1, 50-GGAGAGCCCTGGATACCAA-30 and 50-
TGGTTGTAGAGGGCAAGGAC-30; TNF-a, 50-AATGGCCTCCCTCTCATCAGT
T-30 and 50-CCACTTGGTGGTTTGCTACGA-30.
Histopathology, Morphometric Analysis, Immunohistochemistry,
and Immunofluorescence
Liver tissues were harvested from noninfected or infected mice 40 hr after
infection. Tissues were fixed in Bouin solution or 10% formalin for paraffin
embedding and hematoxylin-eosin (HE) staining and immunohistochemistry.
Inflammatory foci were assessed in pictures of HE-stained sections by mor-
phometric analysis using the ImageJ 1.34s software. The area of inflammatory
foci was normalized to the total area observed.
Immunohistochemistry was performed using anti-HO1 rabbit polyclonal an-
tibody SPA 895 (Stressgen), followed by detection using Envision/HRP/Rabbit
(DakoCytomation). Immunofluorescence studies were performed to stain
macrophages and HO-1 simultaneously. Infected mouse liver sections were
fixed in a mixture of 30% acetone/70% methanol at 20C for 10 min. Block-
ing was performed with 10% fetal bovine serum. Slides were incubated in rab-
bit anti-HO-1 polyclonal antibodies (Stressgen SPA-895) and rat anti-mouse
macrophages, monoclonal clone CI:A3-1 (RDI-T-2008X) overnight. Appropri-
ate fluorescent tagged secondary antibodies were used for detection. Slides
were viewed on a fluorescent microscope with camera (Leica DM5000B).
Isolation of P. yoelii-Infected Hepatocytes
BALB/c mice were infected with GFP-expressing P. yoelii sporozoites, and in-
fected hepatocytes were isolated by FACS at 24 and 40 hr postinfection as
previously described (Tarun et al., 2006). Primary hepatocytes isolated from
mock-infected mice were used as controls.Isolation of Murine Primary Hepatocytes
and Peritoneal Macrophages
Mouse primary hepatocytes were isolated as previously described (Goncalves
et al., 2007). Briefly, cells were initially obtained by perfusion of mouse liver
lobules with liver perfusion medium and liver digest medium (GIBCO) at 37C
using a peristaltic pump. Hepatocytes were then purified using a 1.12 g/ml,
1.08 g/ml, and 1.06 g/ml Percoll gradient. Cells were cultured in William’s E
medium containing 4% FCS and 1% pen/strep in 24-well plates coated with
0.2% gelatin in PBS. Cells were maintained in culture at 37C and 5% CO2.
Peritoneal macrophages were obtained by peritoneal lavage. Briefly, 5 ml of
sterile RPMI supplemented with 5 U/ml heparin was injected into the mice’s
peritoneal cavities, and the contents of the cavities were gently massaged. A
similar volume was then removed from the abdomen, and 106 macrophages
were seeded in a 24-well plate.
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